牛牛AI助理已提取核心訊息
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc. (BLUE), was involved in a transaction with the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Vittiglio after the transaction. The absence of these details leaves the impact of the transaction on Vittiglio's holdings and the company's stock undetermined.
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc. (BLUE), was involved in a transaction with the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Vittiglio after the transaction. The absence of these details leaves the impact of the transaction on Vittiglio's holdings and the company's stock undetermined.
藍鳥生物公司（BLUE）的首席商務和法律官約瑟夫·維蒂格里奧於2024年3月1日參與了與該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關Vittiglio在交易後持有的股票數量的信息。這些細節的缺乏使該交易對維蒂格里奧持股和公司股票的影響尚不確定。
藍鳥生物公司（BLUE）的首席商務和法律官約瑟夫·維蒂格里奧於2024年3月1日參與了與該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關Vittiglio在交易後持有的股票數量的信息。這些細節的缺乏使該交易對維蒂格里奧持股和公司股票的影響尚不確定。
有用
沒用